NCW Libraries

An action-packed FBI thriller from #1 New York Times bestselling author Catherine Coulter!
In Connecticut, the murder of a pharmaceutical bigwig brings in Savich and Sherlock, along with local Agent Bowie Richards and P.I. Erin Pulaski. Back in Washington, an important U.S. senator is terrorized by an unknown entity, and is calling for Savich’s special skills.
When the Vice President is nearly killed, it’s clear these...

In the biggest case of her career, attorney Kate Sullivan has been appointed lead counsel to take on Mason Pharmaceutical in a claim involving an allegedly dangerous new drug. She hires former Army Ranger turned private investigator Landon James to do some digging. When a whistleblower is found dead, it's clear the stakes are higher than ever. Will this case prove deadly for Kate?

Three stories about the world of opioids collide: a drug trafficker arranges a multi-cartel Fentanyl smuggling operation between Canada and the U.S., an architect recovering from an OxyContin addiction tracks down the truth behind her son's involvement with narcotics, and a university professor battles unexpected revelations about his research employer, a drug company with deep government influence bringing a new non-addictive painkiller to market....

A true crime author explores the perspective of doctors who developed early treatments for COVID-19 and their belief that the Bio-Pharmaceutical Complex suppressed it in favor of greed. --

"The blistering inside story of a startup that made millions pushing opioids-until its cutthroat tactics were exposed and its executives put behind bars John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention...

"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?...